Effect of angiotensin recepter blocker vs placebo in hemodialysis patients on residual renal function and cardiovascular status. In addition QoL and inflammatory biomarkers have been studied, and further biomarker and followup studies are ongoing in this investigator initiated multi center randomised controlled trial initiated in Aarhus with Jens Dam Jensen as head of study.

 

Researchers:

  • Jens Dam Jensen
    Associate professor, MD, PhD
  • Krista Dybtved Kjærgaard
    Postdoc, MD, PhD
  • Christian Daugaard Peters
    Postdoc, MD, PhD